Neonatal Detection of Aicardi Goutières Syndrome by Increased C26:0 Lysophosphatidylcholine and Interferon Signature On Newborn Screening Blood Spots.
Document Type
Journal Article
Publication Date
7-20-2017
Journal
Molecular Genetics and Metabolism
DOI
10.1016/j.ymgme.2017.07.006
APA Citation
Armangue, T., Orsini, J., Takanohashi, A., Gavazzi, F., Conant, A., Ulrick, N., Morrissey, M., Nahhas, N., Helman, G., Gordish-Dressman, H., Orcesi, S., Tonduti, D., Stutterd, C., van Haren, K., Toro, C., Iglesias, A., van der Knaap, M., Goldbach Mansky, R., Moser, A., Jones, R., & Vanderver, A. (2017). Neonatal Detection of Aicardi Goutières Syndrome by Increased C26:0 Lysophosphatidylcholine and Interferon Signature On Newborn Screening Blood Spots.. Molecular Genetics and Metabolism, (). http://dx.doi.org/10.1016/j.ymgme.2017.07.006
Peer Reviewed
1
